Stay updated on AV-101 for Levodopa Dyskinesia: PD Clinical Trial
Sign up to get notified when there's something new on the AV-101 for Levodopa Dyskinesia: PD Clinical Trial page.

Latest updates to the AV-101 for Levodopa Dyskinesia: PD Clinical Trial page
- Check2 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed. Notably, the information regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.SummaryDifference2%
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference1%
- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check38 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference2%
- Check67 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content or functionality of the page.SummaryDifference0.1%
- Check81 days agoChange DetectedThe page has undergone significant content removal, particularly regarding a detailed description of a Phase 2 study for AV-101 in Parkinson's Disease, which included inclusion and exclusion criteria for participants. Additionally, a new version number has been introduced.SummaryDifference39%
Stay in the know with updates to AV-101 for Levodopa Dyskinesia: PD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AV-101 for Levodopa Dyskinesia: PD Clinical Trial page.